SCHEMBL1613083

SCHEMBL1613083

COCc1cc(OC)c(C(C)=O)c(OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.53
MAPK1 P28482 2/20 0.53
USP2 O75604 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.41
GAA P10253 3/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.40
MET P08581 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ABL1 P00519 1/20 0.39
POLB P06746 1/20 0.39
RECQL P46063 1/20 0.39
RIN1 Q13671 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20627981 0.85 CA12 (0.52) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL18324957 0.82 CYP3A4 (0.50) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL1662884 0.81 HMGCR (0.46) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL1612678 0.80 HPGDS (0.44) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL4743848 0.79 CYP3A4 (0.66) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL1661748 0.78 ALOX15 (0.38) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL12248741 0.75 CYP3A4 (0.60) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL28325906 0.75 AKR1B1 (0.52) KMT2ALMNAGAAMAPTMET
SCHEMBL2029772 0.75 CYP3A4 (0.78) CYP3A4MAPK1USP2SMN1; SMN2KMT2A
SCHEMBL12712826 0.75 HPGDS (0.40) CYP3A4MAPK1USP2SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530504-B2 Pyrazolothiazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-09-10 US disclosed
US-8431603-B2 3-phenylpyrazolo[5,1-b]thiazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-30 US disclosed
US-8431603-B2 3-phenylpyrazolo[5,1-b]thiazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-30 US disclosed
US-8431603-B2 3-phenylpyrazolo[5,1-b]thiazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-04-30 US disclosed
EP-2266990-B1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND EISAI R&D MAN CO LTD (JP) 2012-09-26 EP disclosed
EP-2266990-B1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND EISAI R&D MAN CO LTD (JP) 2012-09-26 EP disclosed
EP-2487178-A1 PYRAZOLOTHIAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2012-08-15 EP disclosed
US-20110086882-A1 PYRAZOLOTHIAZOLE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-14 US disclosed
EP-2266990-A1 3-PHENYLPYRAZOLOÝ5,1-b¨THIAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2010-12-29 EP disclosed
EP-2266990-A1 3-PHENYLPYRAZOLOÝ5,1-b¨THIAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2010-12-29 EP disclosed
WO-2009128383-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND エーザイ・アール・アンド・ディー・マネジメント株式会社 (JP) 2009-10-22 WO disclosed
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-10-15 US disclosed
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-10-15 US disclosed
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086882-A1 PYRAZOLOTHIAZOLE COMPOUND CRHR1, CNR1, AGTR1 CYP3A4 1353/4885MAPK1 706/4885USP2 4349/4885
US-20090259049-A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUNDS CRHR1, AGTR1, CRHR2 CYP3A4 450/4885MAPK1 308/4885USP2 4390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.